ConductScience.org, home

Paper1362540

Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.

Rastogi N and 6 others. Eur J Clin Microbiol Infect Dis, 1992. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Papers, record 1362540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1362540

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.
PubMed
Journal
Eur J Clin Microbiol Infect Dis
PubMed
Year
1992
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
1.92
iCite
Revised in PubMed
2026-10-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rastogi NN
2Ross BCB C
3Dwyer BB
4Goh KSK S
5Clavel-Sérès SS
6Jeantils VV
7Cruaud PP

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
Drug Resistance, MicrobialMajor topic
Mycobacterium tuberculosisMajor topic
Tuberculosis, PulmonaryMajor topic
Adult
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Bacteriophage Typing
Blotting, Southern
Clofazimine
Colony Count, Microbial
DNA, Bacterial
Fluoroquinolones
Humans
Isoniazid
Lactams, Macrocyclic
Male
Microbial Sensitivity Tests
Polymorphism, Restriction Fragment Length
Rifamycins

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11952872In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1952872PubMed
21977765Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis.J Clin Microbiol1990https://conductscience.org/library/papers/1977765PubMed
31928942Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.Am Rev Respir Dis1991https://conductscience.org/library/papers/1928942PubMed
41672703Differentiation of Mycobacterium tuberculosis strains by use of a nonradioactive Southern blot hybridization method.J Infect Dis1991https://conductscience.org/library/papers/1672703PubMed
51663520Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis.J Clin Microbiol1991https://conductscience.org/library/papers/1663520PubMed
61928940The U-shaped curve of concern.Am Rev Respir Dis1991https://conductscience.org/library/papers/1928940PubMed
77340897[Estimations concerning the world incidence of positive pulmonary tuberculosis from sputum smears. Unreliability of official totals reported on tuberculosis].Bull Int Union Tuberc1981https://conductscience.org/library/papers/7340897PubMed
83165641Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.Ann Inst Pasteur Microbiol1988https://conductscience.org/library/papers/3165641PubMed
92109022Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis.J Infect Dis1990https://conductscience.org/library/papers/2109022PubMed
101672939Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients.Lancet1991https://conductscience.org/library/papers/1672939PubMed
111928943
Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire.
Am Rev Respir Dis1991https://conductscience.org/library/papers/1928943PubMed
121572981Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool.J Clin Microbiol1992https://conductscience.org/library/papers/1572981PubMed
131677943Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis.J Clin Microbiol1991https://conductscience.org/library/papers/1677943PubMed
143146114[Distribution of bacteriophage types of Mycobacterium tuberculosis in France].Rev Mal Respir1988https://conductscience.org/library/papers/3146114PubMed
152495428A strategic plan for the elimination of tuberculosis in the United States.MMWR Morb Mortal Wkly Rep1989https://conductscience.org/library/papers/2495428PubMed
166787076Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.J Clin Microbiol1981https://conductscience.org/library/papers/6787076PubMed
17804840World Health Organization studies on bacteriophage typing of mycobacteria. Subdivision of the species Mycobacterium tuberculosis.Am Rev Respir Dis1975https://conductscience.org/library/papers/804840PubMed
181981088Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family.Mol Microbiol1990https://conductscience.org/library/papers/1981088PubMed
192177747Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis.J Clin Microbiol1990https://conductscience.org/library/papers/2177747PubMed
206439095[Distribution of lysotypes of Mycobacterium tuberculosis in relation to the country of origin of the patient].Ann Microbiol (Paris)1984https://conductscience.org/library/papers/6439095PubMed

See all 21 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
26343800The association between sterilizing activity and drug distribution into tuberculosis lesions.Nat Med2015https://conductscience.org/library/papers/26343800PubMed
23541151Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.Int J Tuberc Lung Dis2013https://conductscience.org/library/papers/23541151PubMed
12453352Mycobacterium tuberculosis transmission between cluster members with similar fingerprint patterns.Emerg Infect Dis2002https://conductscience.org/library/papers/12453352PubMed
11217874The role of fluoroquinolones in tuberculosis today.Drugs2001https://conductscience.org/library/papers/11217874PubMed
10699028Detection of a previously unamplified spacer within the DR locus of Mycobacterium tuberculosis: epidemiological implications.J Clin Microbiol2000https://conductscience.org/library/papers/10699028PubMed
9205846Future directions in the development of new antitubercular drugs. Where do we go from here?Drugs Aging1997https://conductscience.org/library/papers/9205846PubMed
8944606Diagnosis of cutaneous tuberculosis in biopsy specimens by PCR and southern blotting.J Clin Pathol1996https://conductscience.org/library/papers/8944606PubMed
8807049In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8807049PubMed
8727887Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis.J Clin Microbiol1996https://conductscience.org/library/papers/8727887PubMed
8092850Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8092850PubMed
8082292Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.Clin Exp Immunol1994https://conductscience.org/library/papers/8082292PubMed
7736687Clinical pharmacokinetics of rifabutin.Clin Pharmacokinet1995https://conductscience.org/library/papers/7736687PubMed
7690367Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis.J Clin Microbiol1993https://conductscience.org/library/papers/7690367PubMed
7521834Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.Drugs1994https://conductscience.org/library/papers/7521834PubMed
7486904Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7486904PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1362540

GET https://conductscience.org/api/papers/v1/1362540/references?page=2